Nextgen Healthcare Valuation

NXGNDelisted Stock  USD 23.94  0.00  0.00%   
At this time, the firm appears to be overvalued. Nextgen Healthcare secures a last-minute Real Value of $18.7 per share. The latest price of the firm is $23.94. Our model forecasts the value of Nextgen Healthcare from analyzing the firm fundamentals such as Profit Margin of (0.01) %, return on equity of -0.0144, and Current Valuation of 1.68 B as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
23.94
Please note that Nextgen Healthcare's price fluctuation is very steady at this time. Calculation of the real value of Nextgen Healthcare is based on 3 months time horizon. Increasing Nextgen Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Nextgen Healthcare is useful when determining the fair value of the Nextgen stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Nextgen Healthcare. Since Nextgen Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nextgen Stock. However, Nextgen Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  23.94 Real  18.7 Hype  23.94 Naive  23.07
The real value of Nextgen Stock, also known as its intrinsic value, is the underlying worth of Nextgen Healthcare Company, which is reflected in its stock price. It is based on Nextgen Healthcare's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Nextgen Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nextgen Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
18.70
Real Value
26.33
Upside
Estimating the potential upside or downside of Nextgen Healthcare helps investors to forecast how Nextgen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nextgen Healthcare more accurately as focusing exclusively on Nextgen Healthcare's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
23.9423.9423.94
Details
Hype
Prediction
LowEstimatedHigh
23.9423.9423.94
Details
Naive
Forecast
LowNext ValueHigh
23.0723.0723.07
Details

Nextgen Healthcare Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Nextgen Healthcare's current stock value. Our valuation model uses many indicators to compare Nextgen Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nextgen Healthcare competition to find correlations between indicators driving Nextgen Healthcare's intrinsic value. More Info.
Nextgen Healthcare is considered to be number one stock in beta category among related companies. It is considered to be number one stock in net asset category among related companies making up about  1,163,767,532  of Net Asset per Beta. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nextgen Healthcare by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nextgen Healthcare's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nextgen Healthcare's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Nextgen Healthcare's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Nextgen Healthcare and how it compares across the competition.

About Nextgen Healthcare Valuation

The delisted stock valuation mechanism determines the current worth of Nextgen Healthcare on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Nextgen Healthcare. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Nextgen Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing Nextgen Healthcare's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Nextgen Healthcare's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nextgen Healthcare. We calculate exposure to Nextgen Healthcare's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nextgen Healthcare's related companies.
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. NextGen Healthcare, Inc. was incorporated in 1974 and is headquartered in Atlanta, Georgia. Nextgen Healthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2655 people.

8 Steps to conduct Nextgen Healthcare's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nextgen Healthcare's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nextgen Healthcare's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Nextgen Healthcare's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Nextgen Healthcare's revenue streams: Identify Nextgen Healthcare's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Nextgen Healthcare's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Nextgen Healthcare's growth potential: Evaluate Nextgen Healthcare's management, business model, and growth potential.
  • Determine Nextgen Healthcare's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nextgen Healthcare's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Nextgen Healthcare Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Nextgen Healthcare does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding67 M
Quarterly Earnings Growth Y O Y-0.65
Forward Price Earnings17.5439
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Nextgen Healthcare information on this page should be used as a complementary analysis to other Nextgen Healthcare's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Consideration for investing in Nextgen Stock

If you are still planning to invest in Nextgen Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nextgen Healthcare's history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes